The whole blood loop assay
Since 2014, Immuneed has offered a unique, cost-effective, first-in-class extracorporeal whole blood loop assay. The assay measures drug-related rapid infusion reactions mediated by blood components, as well as drug biodistribution and mode-of-action studies. Our advanced characterization services are paired with our immunological know-how and expertise, enabling us to link pre-clinical data to clinical reality.
The whole-blood loop assay is applicable during drug discovery and development – from screening of drug candidates to early clinical development – and is suitable for various drug candidates, including biosimilars, antibodies, peptides and viruses. The assay setup is designed together with you and your team to enhance data output.
Are you interested in using our whole-blood loop model to assess toxicity or/and efficacy of your drug candidate?
Contact us to find out how we can help you!